287
Views
74
CrossRef citations to date
0
Altmetric
Drug Evaluation

Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability

, , &
Pages 505-526 | Published online: 29 Sep 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kathleen M Job, Jessica K Roberts, Elena Y Enioutina, Sílvia M Illamola, Shaun S Kumar, Jahidur Rashid, Robert M Ward, Tsuyoshi Fukuda, Joseph Sherbotie & Catherine M Sherwin. (2021) Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. Expert Opinion on Drug Metabolism & Toxicology 17:7, pages 747-765.
Read now
Burkhard Tönshoff. (2020) Immunosuppressive therapy post-transplantation in children: what the clinician needs to know. Expert Review of Clinical Immunology 16:2, pages 139-154.
Read now
Piero Ruggenenti, Paolo Cravedi & Giuseppe Remuzzi. (2007) Latest treatment strategies for membranous nephropathy. Expert Opinion on Pharmacotherapy 8:18, pages 3159-3171.
Read now

Articles from other publishers (70)

Ole Martin Drevland, Ida Robertsen, Marte Theie Gustavsen, Hanne Kamilla Kveim, Markus Herberg Hovd, Karsten Midtvedt & Anders Åsberg. (2023) Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients. Transplantation Direct 9:3, pages e1448.
Crossref
Burkhard Tönshoff, Anette Melk & Britta Höcker. 2023. Pediatric Kidney Disease. Pediatric Kidney Disease 1849 1886 .
Monika Górska & Ilona Kurnatowska. (2022) Nutrition Disturbances and Metabolic Complications in Kidney Transplant Recipients: Etiology, Methods of Assessment and Prevention—A Review. Nutrients 14:23, pages 4996.
Crossref
Claudia Soledad Sepúlveda, Cybele Carina García & Elsa Beatriz Damonte. (2022) Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy. Microorganisms 10:8, pages 1631.
Crossref
Maria Chitty-Lopez & Jolan E. Walter. 2022. Allergic and Immunologic Diseases. Allergic and Immunologic Diseases 1431 1446 .
Burkhard Tönshoff, Minnie Sarwal, Stephen D. Marks & Asha Moudgil. 2022. Pediatric Nephrology. Pediatric Nephrology 1927 1958 .
Michael Klotsman, Gayatri Sathyan & Wayne H. Anderson. (2021) Single‐dose pharmacokinetics of mycophenolic acid following administration of immediate‐release mycophenolate mofetil in healthy Beagle dogs. Journal of Veterinary Pharmacology and Therapeutics 44:4, pages 650-656.
Crossref
Nut Koonrungsesomboon, Nuttapong Ngamphaiboon, Natavudh Townamchai, Pimpisa Teeyakasem, Chaiyut Charoentum, Pimlak Charoenkwan, Rungrote Natesirinilkul, Lalita Sathitsamitphong, Touch Ativitavas, Parunya Chaiyawat, Jeerawan Klangjorhor, Suradej Hongeng & Dumnoensun Pruksakorn. (2020) Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial. BMC Cancer 20:1.
Crossref
David I. Harriman & Jeffrey Rogers. 2020. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 217 228 .
Matthew H. H. Young, Dawn Truong, Jana Ekberg & Stefan G. Tullius. 2020. Uterus Transplantation. Uterus Transplantation 151 166 .
Jürg Oliver Straub, Rik Oldenkamp, Thomas Pfister & Andreas Häner. (2019) Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters. Environmental Toxicology and Chemistry 38:10, pages 2259-2278.
Crossref
Michael Klotsman, Gayatri Sathyan, Wayne H. Anderson, Oliver A. Garden & Padmaja Shivanand. (2019) Mycophenolic acid in patients with immune-mediated inflammatory diseases: From humans to dogs. Journal of Veterinary Pharmacology and Therapeutics 42:2, pages 127-138.
Crossref
Burkhard Tönshoff. 2020. Pediatric Pharmacotherapy. Pediatric Pharmacotherapy 441 469 .
Keiko Hosohata, Etsuko Matsuoka, Ayaka Inada, Saki Oyama, Iku Niinomi, Yasuhiro Mori, Yuki Yamaguchi, Mayako Uchida & Kazunori Iwanaga. (2018) Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients. Journal of International Medical Research 46:11, pages 4617-4623.
Crossref
Qiao Huang, Jingqi Wang, Yifan Zhou, Hui Yang, Zhanhang Wang, Zhenwen Yan, Youming Long, Jia Yin, Huiyu Feng, Caixia Li, Zhengqi Lu, Xueqiang Hu & Wei Qiu. (2018) Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China. Frontiers in Immunology 9.
Crossref
David Pellerin, Kelita Singh, Thomas Maniatis, Colin H. Chalk & Laurence Green. (2018) Mycophenolate Mofetil-Induced Status Epilepticus. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:5, pages 585-587.
Crossref
Wen Dang, Yuebang Yin, Yijin Wang, Wenshi Wang, Junhong Su, Dave Sprengers, Luc J. W. van der Laan, Krzysztof Felczak, Krzysztof W. Pankiewicz, Kyeong-Ok Chang, Marion P. G. Koopmans, Herold J. Metselaar, Maikel P. Peppelenbosch & Qiuwei Pan. (2017) Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. Antimicrobial Agents and Chemotherapy 61:11.
Crossref
Svenja Heischmann, Monika Dzieciatkowska, Kirk Hansen, Dieter Leibfritz & Uwe Christians. (2017) The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model. Scientific Reports 7:1.
Crossref
Y. Shi, H. Liu, X.-G. Chen & Z.-Y. Shen. (2017) Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China. Transplantation Proceedings 49:1, pages 26-31.
Crossref
Jacek P. Szaflik, Joanna Major, Justyna Izdebska, Mieczysław Lao & Jerzy Szaflik. (2015) Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study. Graefe's Archive for Clinical and Experimental Ophthalmology 254:2, pages 307-314.
Crossref
Burkhard T?nshoff, Anette Melk & Britta H?cker. 2016. Pediatric Kidney Disease. Pediatric Kidney Disease 1767 1802 .
Darinka Todorova Petrova, Gunnar Brandhorst, Christian Koch, Frank Christian Schultze, Christoph Eberle, Philip D. Walson & Michael Oellerich. (2015) Mycophenolic acid reverses TGF beta-induced cell motility, collagen matrix contraction and cell morphology in vitro . Cell Biochemistry and Function 33:7, pages 503-508.
Crossref
Darinka Todorova Petrova, Frank Christian Schultze, Gunnar Brandhorst, Klaus-Dieter Luchs, Christof Lenz, Henning Urlaub, Diana Rubel, Oliver Gross, Philip D Walson & Michael Oellerich. (2014) Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice. Proteome Science 12:1.
Crossref
Azza A.K. El-Sheikh, Jan B. Koenderink, Alfons C. Wouterse, Petra H.H. van den Broek, Vivienne G.M. Verweij, Rosalinde Masereeuw & Frans G.M. Russel. (2014) Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Translational Research 164:1, pages 46-56.
Crossref
Muhammad Qasim, Hazir Rahman, Raees Ahmed, Michael Oellerich & Abdul R. Asif. (2014) Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. Experimental Cell Research 322:2, pages 277-289.
Crossref
Hao Chen. (2014) Clinical mycophenolic acid monitoring in liver transplant recipients. World Journal of Gastroenterology 20:31, pages 10715.
Crossref
Phani Krishna Kondamudi, Rajkumar Malayandi, Chandramohan Eaga & Deepika Aggarwal. (2013) Drugs as causative agents and therapeutic agents in inflammatory bowel disease. Acta Pharmaceutica Sinica B 3:5, pages 289-296.
Crossref
Azrin N. Abd Rahman, Susan E. Tett & Christine E. Staatz. (2013) Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease. Clinical Pharmacokinetics 52:5, pages 303-331.
Crossref
Marie-France Dubeau, Marietta Iacucci, Paul L. Beck, Gordon W. Moran, Gilaad G. Kaplan, Subrata Ghosh & Remo Panaccione. (2013) Drug-Induced Inflammatory Bowel Disease and IBD-Like Conditions. Inflammatory Bowel Diseases 19:2, pages 445-456.
Crossref
Qiuwei Pan, Hugo W. Tilanus, Herold J. Metselaar, Harry L. A. Janssen & Luc J. W. van der Laan. (2012) Virus–drug interactions—molecular insight into immunosuppression and HCV. Nature Reviews Gastroenterology & Hepatology 9:6, pages 355-362.
Crossref
Laurence Chan, Amado Andres, Suphamai Bunnapradist, Kristene Gugliuzza, Ravi Parasuraman, V. Ram Peddi, Elisabeth Cassuto & Marquis Hart. (2012) Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS . Journal of Transplantation 2012, pages 1-9.
Crossref
Sylvia Stracke, Maria Shipkova, Jens Mayer, Frieder Keller, Amir Zarghom, Liying Yang, Doris Henne‐Bruns & Eberhard Wieland. (2011) Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC‐MPS) co‐administered with cyclosporine in the early‐phase post‐kidney transplantation. Clinical Transplantation 26:1, pages 57-66.
Crossref
Na Yang, Qing-He Wang, Wen-Qian Wang, Jian Wang, Feng Li, Shen-Peng Tan & Mao-Sheng Cheng. (2012) The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives. Bioorganic & Medicinal Chemistry Letters 22:1, pages 53-56.
Crossref
Muhammad Qasim, Hazir Rahman, Michael Oellerich & Abdul R Asif. (2011) Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment. Proteome Science 9:1.
Crossref
E. Epailly, J. Albanell, A. Andreassen, C. Bara, J.M. Campistol, J.F. Delgado, H. Eisen, A.E. Fiane, P. Mohacsi, S. Schubert, L. Sebbag, F.M. Turazza, H. Valantine, A. Zuckermann & L. Potena. (2011) Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. Clinical Transplantation 25:5, pages E475-E486.
Crossref
H. Malekinejad, H. Cheraghi, A. Alizadeh, M.H. Khadem-Ansari, A.A. Tehrani & S. Varasteh. (2011) Nitric Oxide and Acute Phase Proteins Are Involved in Pathogenesis of Mycophenolate Mofetil–Induced Gastrointestinal Disorders in Rats. Transplantation Proceedings 43:7, pages 2741-2746.
Crossref
Burkhard T?nshoff, Elias David-Neto, Robert Ettenger, Guido Filler, Teun van Gelder, Jens Goebel, Dirk R.J. Kuypers, Eileen Tsai, Alexander A. Vinks, Lutz T. Weber & Lothar Bernd Zimmerhackl. (2011) Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Transplantation Reviews 25:2, pages 78-89.
Crossref
Ian AC Rowe & James M Neuberger. 2011. Primer on Transplantation. Primer on Transplantation 18 34 .
Susanne Beckebaum & Vito R. Cicinnati. (2010) Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?. Digestive Diseases and Sciences 56:1, pages 4-6.
Crossref
Tomonori Nakanishi, Tatsuaki Morokata, Takahisa Noto, Kaori Kubo, Hitomi Umeno, Fumitaka Kinugasa, Yoshiteru Eikyu, Yoshihiro Kozuki & Nobuo Seki. (2010) Effect of the inosine 5?-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats. International Immunopharmacology 10:11, pages 1434-1439.
Crossref
Darinka T Petrova, Gunnar Brandhorst, Franziska Brehmer, Oliver Gross, Michael Oellerich & Victor W Armstrong. (2010) Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function. Therapeutic Drug Monitoring 32:4, pages 405-412.
Crossref
Maria Rosa Costanzo, Maria Rosa Costanzo, Anne Dipchand, Randall Starling, Allen Anderson, Michael Chan, Shashank Desai, Savitri Fedson, Patrick Fisher, Gonzalo Gonzales-Stawinski, Luigi Martinelli, David McGiffin, Francesco Parisi, Jon Smith, David Taylor, Bruno Meiser, Steven Webber, David Baran, Michael Carboni, Thomas Dengler, David Feldman, Maria Frigerio, Abdallah Kfoury, Daniel Kim, Jon Kobashigawa, Michael Shullo, Josef Stehlik, Jeffrey Teuteberg, Patricia Uber, Andreas Zuckermann, Sharon Hunt, Michael Burch, Geetha Bhat, Charles Canter, Richard Chinnock, Marisa Crespo-Leiro, Reynolds Delgado, Fabienne Dobbels, Kathleen Grady, Kao W, Jaqueline Lamour, Gareth Parry, Jignesh Patel, Daniela Pini, Sean Pinney, Jeffrey Towbin, Gene Wolfel, Diego Delgado, Howard Eisen, Lee Goldberg, Jeff Hosenpud, Maryl Johnson, Anne Keogh, Clive Lewis, John O'Connell, Joseph Rogers, Heather Ross, Stuart Russell & Johan Vanhaecke. (2010) The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. The Journal of Heart and Lung Transplantation 29:8, pages 914-956.
Crossref
Zhang Wei Xia, Chen Yong Jun, Chen Hao, Chen Bing, Shi Min Min & Xie Jun Jie. (2010) The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients. European Journal of Clinical Pharmacology 66:7, pages 671-679.
Crossref
N. Kemmer & G. Neff. (2010) Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation. Transplantation Proceedings 42:5, pages 1731-1737.
Crossref
M. Salvadori, E. Bertoni, K. Budde, H. Holzer, G. Civati, B. Lien & W. Arns. (2010) Superior Efficacy of Enteric-coated Mycophenolate vs Mycophenolate Mofetil in De Novo Transplant Recipients: Pooled Analysis. Transplantation Proceedings 42:4, pages 1325-1328.
Crossref
Maria Shipkova, Ekkehard Schütz, Ingo Besenthal, Peter Fraunberger & Eberhard Wieland. (2010) Investigation of the Crossreactivity of Mycophenolic Acid Glucuronide Metabolites and of Mycophenolate Mofetil in the Cedia MPA Assay. Therapeutic Drug Monitoring 32:1, pages 79-85.
Crossref
Gunnar Brandhorst, Franziska Brehmer, Darinka T Petrova, Oliver Gross, Nicolai Miosge, Victor W Armstrong & Michael Oellerich. (2010) Mycophenolic Acid Predose Concentrations and Renal Function in a Mouse Model for Progressive Renal Fibrosis. Therapeutic Drug Monitoring 32:1, pages 73-78.
Crossref
L. Frimat, E. Cassuto-Viguier, F. Prov?t, L. Rostaing, B. Charpentier, K. Akposso, M. C. Moal, P. Lang, D. Glotz, S. Caillard, D. Ducloux, C. Pouteil-Noble, S. Girardot-Seguin & M. Kessler. (2010) Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up. Journal of Transplantation 2010, pages 1-11.
Crossref
Tomonori Nakanishi, Tatsuaki Morokata, Kaori Kubo, Hitomi Umeno, Yoshiteru Eikyu, Yoshihiro Kozuki & Nobuo Seki. (2010) Effect of the inosine 5?-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection. International Immunopharmacology 10:1, pages 91-97.
Crossref
Horst Feichtiger, Eberhard Wieland, Victor W. Armstrong & Maria Shipkova. (2010) The acyl glucuronide metabolite of mycophenolic acid induces tubulin polymerization in vitro. Clinical Biochemistry 43:1-2, pages 208-213.
Crossref
Rebecca G. Pomerantz, Thomas S. Kupper & Abrar A. Qureshi. 2010. Therapy of Skin Diseases. Therapy of Skin Diseases 29 38 .
Amy E. Jones, Helen K. Wilson, Paul Meath, Xiaoli Meng, David W. Holt, Atholl Johnston, Michael Oellerich, Victor W. Armstrong & Andrew V. Stachulski. (2009) Convenient syntheses of the in vivo carbohydrate metabolites of mycophenolic acid: reactivity of the acyl glucuronide. Tetrahedron Letters 50:35, pages 4973-4977.
Crossref
Persis P. Wadia, Nancy D. Herrera, Michael M. Abecassis & Anat R. Tambur. (2009) Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells. Human Immunology 70:9, pages 692-700.
Crossref
Tanja Heller, Abdul R Asif, Darinka Todorova Petrova, Yuliana Doncheva, E Wieland, Michael Oellerich, Maria Shipkova & Victor William Armstrong. (2009) Differential Proteomic Analysis of Lymphocytes Treated With Mycophenolic Acid Reveals Caspase 3-Induced Cleavage of Rho GDP Dissociation Inhibitor 2. Therapeutic Drug Monitoring 31:2, pages 211-217.
Crossref
Susanne Beckebaum, Georgios C. Sotiropoulos, Christian G. Klein, Christoph E. Broelsch, Fuat Saner, Andreas Paul, Guido Gerken & Vito R. Cicinnati. (2009) Predictive Factors of Outcome in Patients Transplanted for Hepatitis B. Transplantation 87:6, pages 872-881.
Crossref
Maria Shipkova. (2009) Clinical utility of therapeutic drug monitoring of mycophenolic acid in transplantation medicine: Where are we? / Der klinische Nutzen des Therapeutischen Drug Monitoring von Mycophenolsäure in der Transplantationsmedizin: Wo stehen wir?. LaboratoriumsMedizin 33:2, pages 88-98.
Crossref
Flora Tshinanu Musuamba, Vincent Di Fazio, Roger Vanbinst & Pierre Wallemacq. (2009) A Fast Ultra-Performance Liquid Chromatography Method for Simultaneous Quantification of Mycophenolic Acid and Its Phenol- and Acyl-Glucuronides in Human Plasma. Therapeutic Drug Monitoring 31:1, pages 110-115.
Crossref
Monica Mischitelli, Anna Bellizzi, Elena Anzivino, Daniela Fioriti, Renzo Boldorini, Umberto Miglio, Fernanda Chiarini, Franco Di Monaco & Valeria Pietropaolo. (2008) Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually available. Virology Journal 5:1.
Crossref
Hao Chen, Zhidong Gu, Bing Chen, Huarong Mao, Weixia Zhang & Qishi Fan. (2008) Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in chinese patients undergoing liver transplantation. Clinical Therapeutics 30:12, pages 2387-2401.
Crossref
Javier Segovia, Gino Gerosa, Luis Almenar, Ugolino Livi, Mario Viganò, Jose Maria Arizón, Nizar Yonan, Thomas G. Di Salvo, Dale G. Renlund & Jon A. Kobashigawa. (2008) Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation. Clinical Transplantation 22:6, pages 809-814.
Crossref
Henrik Ekberg. (2008) Calcineurin Inhibitor Sparing in Renal Transplantation. Transplantation 86:6, pages 761-767.
Crossref
Gunnar Brandhorst, Pierre Marquet, Leslie M Shaw, Gerhard Liebisch, Gerd Schmitz, Mary Jane Coffing, Ingrid Domke, Frank Streit, Hilmar Luthe & Michael Oellerich. (2008) Multicenter Evaluation of a New Inosine Monophosphate Dehydrogenase Inhibition Assay for Quantification of Total Mycophenolic Acid in Plasma. Therapeutic Drug Monitoring 30:4, pages 428-433.
Crossref
Chen Hao, Mao Anwei, Chen Bing, Shen Baiyong, Zhang Weixia, Shen Chuan, Chen Erzhen, Deng Xiaxing, Qiu Weihua, Yang Weiping, Peng Chenghong & Li Hongwei. (2008) Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: Prediction of occurrence of leukopenia. Liver Transplantation 14:8, pages 1165-1173.
Crossref
Tanja Heller, Anna Geide, Ulrike Bonitz, Ulrike Wegner, Hermann-Josef Gröne, Victor W. Armstrong & Michael Oellerich. (2008) Effect of the Antioxidant Idebenone on Adverse Events Under Mycophenolate Mofetil Therapy in a Rat Model. Transplantation 85:5, pages 739-747.
Crossref
Annick Breton, Benoît Pinson, Fanny Coulpier, Marie-France Giraud, Alain Dautant & Bertrand Daignan-Fornier. (2008) Lethal Accumulation of Guanylic Nucleotides in Saccharomyces cerevisiae HPT1 -Deregulated Mutants . Genetics 178:2, pages 815-824.
Crossref
Burkhard T?nshoff & Anette Melk. 2008. Comprehensive Pediatric Nephrology. Comprehensive Pediatric Nephrology 905 929 .
S. Schrepfer, T. Deuse, H. Reichenspurner, J. Hoffmann, M. Haddad, J. Fink, M.P. Fischbein, R.C. Robbins & M.P. Pelletier. (2007) Effect of Inhaled Tacrolimus on Cellular and Humoral Rejection to Prevent Posttransplant Obliterative Airway Disease. American Journal of Transplantation 7:7, pages 1733-1742.
Crossref
Scott H. Watterson, Ping Chen, Yufen Zhao, Henry H. Gu, T. G. Murali Dhar, Zili Xiao, Shelley K. Ballentine, Zhongqi Shen, Catherine A. Fleener, Katherine A. Rouleau, Mary Obermeier, Zheng Yang, Kim W. McIntyre, David J. Shuster, Mark Witmer, Donna Dambach, Sam Chao, Arvind Mathur, Bang-Chi Chen, Joel C. Barrish, Jeffrey A. Robl, Robert Townsend & Edwin J. Iwanowicz. (2007) Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase:  Discovery and SAR Leading to the Identification of N -(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419) . Journal of Medicinal Chemistry 50:15, pages 3730-3742.
Crossref
Abdul R. Asif, Victor W. Armstrong, Antje Voland, Eberhard Wieland, Michael Oellerich & Maria Shipkova. (2007) Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie 89:3, pages 393-402.
Crossref
Michael Oellerich & Victor W Armstrong. (2006) The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments. Therapeutic Drug Monitoring 28:6, pages 719-725.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.